Vaccination Drive May Help Combat Japanese Encephalitis

by Bidita Debnath on  November 19, 2017 at 11:56 PM Tropical Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

Japanese encephalitis virus (JEV) is a flavivirus related to dengue, yellow fever and West Nile viruses, and is spread by mosquitoes. JEV is the main cause of viral encephalitis in many countries of Asia. The Odisha government will launch a massive vaccination drive to combat killer Japanese Encephalitis (JE) in 13 districts of the state.
Vaccination Drive May Help Combat Japanese Encephalitis
Vaccination Drive May Help Combat Japanese Encephalitis

The campaign, starting November 27, will continue for nearly 20 days. Over 71 lakh children in the age group of 1 year to 15 years would be vaccinated with one dose of the Japanese Encephalitis vaccine during the campaign.

Show Full Article


The disease had killed over 100 children in the state last year, said sources. The vaccination campaign will be launched in Balasore, Cuttack, Dhenkanal, Ganjam, Kalahandi, Kendrapara, Khurda, Koraput, Nabarangpur, Puri, Rayagada, Sonepur and Sundergarh.

In a joint letter, Health secretary P.K. Meherda and Panchayati Raj Secretary Deoranjan Kumar Singh asked the district collectors in the 13 identified districts and Bhubaneswar Municipal Corporation (BMC) Commissioner to assess the actual beneficiary load and prepare an action plan.

"After completion of the campaign, JE vaccine will be included in the routine immunisation programme. In this context, support of the District Panchayat Officer and PRI members for the activities to achieve 100 percent coverage during the campaign," the letter said.

The letter instructed to create community awareness for vaccination campaign, community mobilisation for achieving the target, to discuss the benefits of vaccination during Gramsabha and Gram Panchayat meetings and also to monitor the school and community level campaign activities.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive